Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategy

Sun, R; Meng, YT; Xu, R; Li, Y; Xu, XB; Li, ZQ; Zuo, DY

Zuo, DY (通讯作者)，Shenyang Pharmaceut Univ, All Partner Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China.

CELLULAR SIGNALLING, 2023; 101 ():

Abstract

Targeted therapy is an essential treatment for non-small cell lung cancer (NSCLC) that is always associated with the drug resistance. c-ros oncogene 1......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索